PTGS2 and gastric cancer: The combined dose of harmine and paclitaxel resulted in a synergistic anti-cancer effect that, in turn, downregulated matrix metallopeptidase 9 (MMP-9) and cyclooxygenase 2 (COX-2) in the gastric cancer cell lines, reducing proliferation and leading to apoptosis [64].